MITEC Medical
Identify and Refer Peripheral Artery Disease (PAD) Patients with Confidence in Jamaica
Enhance Your Clinical Approach to PAD Patients
Peripheral Artery Disease (PAD) is increasingly prevalent in Jamaica and often underdiagnosed in primary care. Early identification and timely referral are key to improving patient outcomes.
At MITEC Medical, authorized distributor of Boston Scientific in Jamaica, we support internists and general practitioners with access to advanced solutions and a network of PAD specialists.
Our goal is to help you improve clinical decision making and ensure timely referral for optimal patient care.
Advanced Peripheral Intervention Solutions
The following technologies from Boston Scientific are used by a network of doctors to treat patients with
Peripheral Artery Disease (PAD) in Jamaica.
Early referral can help ensure your patients benefit from these advanced treatment options.
Jetstream Atherectomy System
A versatile atherectomy platform designed to treat both above- and below-the-knee lesions, including calcified plaque.
Key benefits include:
- Active aspiration to help reduce embolic burden
- Dual cutting capability for efficient plaque removal
- And support for vessel preparation prior to adjunctive therapy
OptiCross™ 18 Imaging Catheter
An intravascular ultrasound (IVUS) catheter engineered to provide high-resolution imaging for peripheral interventions.
Key benefits include:
- Clear visualization of vessel morphology and lesion characteristics
- Accurate vessel sizing and treatment planning
- Enhanced procedural confidence and decision-making
Ranger™ Drug-Coated Balloon
A low-dose drug-coated balloon designed to treat superficial femoral artery (SFA) and popliteal lesions.
Key benefits include:
- Efficient drug transfer with a low drug dose
- Designed to reduce restenosis
- Maintains vessel flexibility without leaving a permanent implant
- Feature/Benefit 4
Eluvia™ Drug-Eluting Vascular Stent System
A polymer-based drug-eluting stent designed for sustained drug release in the treatment of PAD.
Key benefits include:
- Controlled and sustained drug delivery
- Proven long-term patency outcomes
- Adapts to vessel movement in the femoropopliteal artery
